<a href="https://www.fiercebiotech.com/medtech/mckesson-swaps-minority-stake-surgical-unit-apollo-funds-125b" hreflang="en">McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B</a>
McKesson has sold a 13% minority stake in its medical/surgical solutions division to Apollo Funds for $1.25 billion as part of its strategy to prepare the unit for an initial public offering next year, while maintaining majority ownership and operational control. This deal values the division at approximately $13 billion and aims to support its growth amidst recent sluggish performance.
McKesson's strategic move to divest a minority stake of its medical/surgical solutions division to Apollo Funds for $1.25 billion, with an eye on a future IPO, signals an opportunity to track the division's standalone growth potential and public market entry. As this development unfolds, it could present investment opportunities and insights into how large healthcare companies are leveraging private equity to optimize their operations and financial strategies in the medtech space.